RT Journal Article SR Electronic T1 Comparison of 18F-FDG and 11C-Methionine for PET-Guided Stereotactic Brain Biopsy of Gliomas JF Journal of Nuclear Medicine JO J Nucl Med FD Society of Nuclear Medicine SP 1293 OP 1298 VO 45 IS 8 A1 Benoit Pirotte A1 Serge Goldman A1 Nicolas Massager A1 Philippe David A1 David Wikler A1 Arlette Vandesteene A1 Isabelle Salmon A1 Jacques Brotchi A1 Marc Levivier YR 2004 UL http://jnm.snmjournals.org/content/45/8/1293.abstract AB We compared the contributions of the labeled tracers 11C-methionine (Met) and 18F-FDG for PET-guided stereotactic biopsy of brain gliomas. Methods: In 32 patients with glioma, stereotactic Met PET and 18F-FDG PET were integrated in the planning of stereotactic brain biopsy. PET images were analyzed to determine which tracer offered the best information for target definition. The stereotactic coregistration of PET images allowed accurate comparison of the level, distribution, and extent of uptake for both tracers according to tumor location and grade. Results: A histologic diagnosis was obtained for all patients. All gliomas had an area of abnormal Met uptake, and 27 showed abnormal 18F-FDG uptake. 18F-FDG was used for target selection when its uptake was higher in tumor than in gray matter (14 gliomas). Seven were in the basal ganglia or brain stem. Met was used for target selection when there was no 18F-FDG uptake or when 18F-FDG uptake was equivalent to that in the gray matter (18 gliomas). Thirteen were in the cortex. Sixty-one of the 70 stereotactic trajectories obtained from the 32 patients were based on PET-defined targets and had an area of abnormal Met uptake. These 61 Met-positive trajectories always yielded a diagnosis of tumor. All nondiagnostic trajectories (n = 9) were obtained in areas with no increased uptake of Met. In all patients with increased uptake of both tracers, the focus of highest Met uptake corresponded to the focus of highest 18F-FDG uptake. However, the extent of uptake of both tracers was variable. Conclusion: Distributions of highest Met and 18F-FDG uptake are similar in brain gliomas. Because Met provides a more sensitive signal, it is the molecule of choice for single-tracer PET-guided neurosurgical procedures in gliomas.